Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
The University of Texas Health Science Center, Houston
With
Texas Higher Education Coordinating Board
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Age
4–16
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
Healthy children with autism spectrum disorders (4 - 16 years old) and gastrointestinal symptoms, based on the GI Severity Index, with no other recognized illness will be enrolled in this study. There will be no selection on the basis of age, race, or gender. Although the investigators anticipate the majority of subjects will be male and/or pre-pubertal, in females of childbearing potential, a pregnancy test (urine) will be performed on females participating (at each visit).
You may not be if
Pregnancy or breastfeeding
Subjects taking immunosuppressive medications, including oral corticosteroids
A History of Positive result of HIV, Hepatitis B, and/or Hepatitis C test
Abnormal lab test results (Section 5.2)
Gastrointestinal diseases such as celiac disease, inflammatory bowel disease
Subjects with an allergy to antibiotics
Presence of fever or a pre-existing adverse event monitored in the study
Use of probiotics in the last 30 days
Acute diarrheal illness within the past 30 days
Recent (within 2 weeks) or current use of oral antibiotics /anti-fungals Current use of oral laxatives
Subjects with implanted prosthetic devices including prosthetic heart valves
The investigators will require that subject not take any other probiotic-containing products, including yogurt supplemented with probiotics during the study period.
Clareo Health | Combination Probiotic: BB-12 With LGG (Different Doses) in Treating Children With Autism Spectrum Disorder
